Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of oral nutritional supplements (ONS) on growth outcomes and IGF-1 level in underweight older children and young adolescents (5-14 years) with short stature and no systemic disease: High versus normal calories density formula.
De Sanctis V, Soliman A, Elsiddig S, Alyafei F, Alaaraj N, Itani M, Jour C, Elawwa A. De Sanctis V, et al. Among authors: elawwa a. Acta Biomed. 2021 Sep 2;92(4):e2021320. doi: 10.23750/abm.v92i4.11868. Acta Biomed. 2021. PMID: 34487062 Free PMC article. Clinical Trial.
Linear growth and circulating insulin-like growth factor I in children with tufting enteropathy receiving long-term TPN.
Soliman AT, Abdel Rahman H, Ali WS, Elawwa A, Al-Arag N, Badran HM. Soliman AT, et al. Among authors: elawwa a. J Pediatr Gastroenterol Nutr. 2012 Aug;55(2):157-9. doi: 10.1097/MPG.0b013e318253b80a. J Pediatr Gastroenterol Nutr. 2012. Retraction in: J Pediatr Gastroenterol Nutr. 2014 Mar;58(3):391. doi: 10.1097/MPG.0000000000000341 PMID: 22411267 Retracted.
Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
Soliman A, Rogol AD, Elsiddig S, Khalil A, Alaaraj N, Alyafie F, Ahmed H, Elawwa A. Soliman A, et al. Among authors: elawwa a. J Pediatr Endocrinol Metab. 2021 Jul 22;34(10):1263-1271. doi: 10.1515/jpem-2021-0389. Print 2021 Oct 26. J Pediatr Endocrinol Metab. 2021. PMID: 34291621 Clinical Trial.
35 results